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Infection initiationTo gain a more complete understanding of hepatitis C virus (HCV) entry, we initially assessed the rate at
which HCV initiates productive attachment/infection in vitro and discovered it to be slower than most
viruses. Since HCV, including cell culture-derived HCV (HCVcc), exhibits a broad-density proﬁle (1.01–
1.16 g/ml), we hypothesized that the varying densities of the HCVcc particles present in the inoculum may
be responsible for this prolonged entry phenotype. To test this hypothesis, we show that during infection,
particles of high density disappeared from the viral inoculum sooner and initiated productive infection faster
than virions of low density. Moreover, we could alter the rate of attachment/infection initiation by
increasing or decreasing the density of the cell culture medium. Together, these ﬁndings demonstrate that
the relationship between the density of HCVcc and the density of the extracellular milieu can signiﬁcantly
impact the rate at which HCVcc productively interacts with target cells in vitro.Section of Hepatology, The
C 787, Chicago, IL 60612, USA.
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Hepatitis C virus (HCV), a positive-strand RNA ﬂavivirus, is a major
cause of liver disease worldwide, including cirrhosis and hepatocel-
lular carcinoma (Poynard et al., 2000, 2003). Since the discovery of
HCV in 1989 as the causative agent of “non-A non-B hepatitis” (Choo
et al., 1989), a major obstacle impeding HCV research has been the
lack of robust cell culture and small animal infection models. To
circumvent these limitations, alternate systems based on selectable
replication-competent HCV RNAs, known as replicons (Blight et al.,
2000, 2003; Ikeda et al., 2002; Lohmann et al., 1999), and
pseudotyped particles (HCVpp) (Bartosch et al., 2003a) were
developed and have provided signiﬁcant insight into HCV replication
and entry, respectively. These systems were limited in that they did
not recapitulate the entire viral lifecycle; however, with the 2005
establishment of the HCV infectious cell culture system (Lindenbach
et al., 2005; Wakita et al., 2005; Zhong et al., 2005), based on a
genotype 2a HCV consensus clone (JFH-1) (Kato et al., 2001, 2003)
that can replicate and produce infectious HCV in cell culture (HCVcc),
we now possess the means to examine the entire viral lifecycle in
detail and possibly learn how to exploit key steps as potential drugtargets. In particular, HCV entry represents a “promisingmulti-faceted
opportunity for drug discovery” [reviewed byMeanwell (2006)], but a
deeper understanding of the process is needed to facilitate such
endeavors.
The HCV particle itself consists of a positive-strand RNA genome
surrounded by a nucleocapsid and a lipid bilayer containing two viral
envelope glycoproteins, E1 (residues 192–383) and E2 (residues 384–
746), which form a non-covalent heterodimer complex on the surface
of the viral particle believed to mediate host cell receptor binding
(Moradpour et al., 2007). HCV particles in patient serum and in vitro
exist as low-density lipoprotein (LDL)–virus complexes (Andre et al.,
2002; Gastaminza et al., 2006, 2008). They are associated with
triglycerides, β-lipoproteins (very-low-density lipoproteins [VLDL]
and LDL) (Gastaminza et al., 2008; Nielsen et al., 2006; Thomssen
et al., 1992, 1993), cholesterol and sphingomyelin (Aizaki et al., 2008;
Kapadia et al., 2007), all of which contribute to the unique broad
buoyant density proﬁle (Andre et al., 2002; Gastaminza et al., 2006,
2008; Lindenbach et al., 2005; Pumeechockchai et al., 2002; Zhong
et al., 2005) of the virus and appear to play a critical role in viral entry
and fusion (Aizaki et al., 2008; Haid et al., 2009; Kapadia et al., 2007;
Lavillette et al., 2006). In patients, serum HCV (HCVser) has a buoyant
density proﬁle of ~1.03–1.13 g/ml, with the majority of HCV RNA
detectable at 1.08 g/ml and below (Andre et al., 2002). The density
proﬁle of HCVcc shows a similar broad HCV RNA distribution from
1.01 to 1.16 g/ml, but exhibits an additional peak of relatively non-
infectious RNA at ~1.12 g/ml. Like HCVser (Bradley et al., 1991),
Fig. 1. Multi-phasic time course of HCVcc infection initiation in Huh7 cells. Huh7 cells
were plated in 96-well plates and cultures infected with ~100 FFU of HCVccwt. At
indicated time points p.i., inoculum was removed from triplicate wells, cells were
washed twice with 1× PBS and overlaid with 10% cDMEM containing 0.25%
methylcellulose. Forty-eight hours p.i., HCV foci were visualized by HRP-based
immunocytochemistry staining using an anti-NS5A antibody, quantiﬁed and are
expressed as mean number (no.) of foci detected/well ± standard deviation (stdev)
for triplicate samples. The slope of foci increase for each of the three phases of HCVcc
foci formation were calculated (solid lines). p≤0.05 represents foci slope different than
zero.
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(Haid et al., 2009; Lindenbach et al., 2005; Zhong et al., 2006) con-
sistent with lipoproteins being important for HCV infectivity.
In vitro, four cell surface receptors, the tetraspanin protein CD81
(Bartosch et al., 2003a; Hsu et al., 2003; Pileri et al., 1998;
Wunschmann et al., 2000; Zhong et al., 2005), the scavenger receptor
class B member I (Bartosch et al., 2003a; Grove et al., 2007; Kapadia
et al., 2007; Scarselli et al., 2002; Zeisel et al., 2007), and the tight
junction proteins claudin-1 (Evans et al., 2007) and occludin
(Benedicto et al., 2009; Liu et al., 2009; Ploss et al., 2009) have been
shown to be required for HCVcc entry. In addition, the low-density
lipoprotein receptor (Agnello et al., 1999; Molina et al., 2007;
Monazahian et al., 1999; Wunschmann et al., 2000), asialoglycopro-
tein receptor (Saunier et al., 2003), glycosaminoglycans (heparan
sulfate) (Barth et al., 2003, 2006; Bartosch et al., 2003a) and
protocadherin β5 (Wong-Staal et al., 2008) have been implicated.
Following a relatively undeﬁned multi-step binding process, HCV
enters the cell via clathrin-mediated endocytosis (Blanchard et al.,
2006; Meertens et al., 2006) and fusion between the virion envelope
and the endosomal membrane occurs in the acidiﬁed endosomal
compartment (Bartosch et al., 2003a,b; Haid et al., 2009; Hsu et al.,
2003; Koutsoudakis et al., 2006; Lavillette et al., 2006; Tscherne et al.,
2006) resulting in nucleocapsid release into the cytoplasm. To expand
our working knowledge of HCV entry we sought to assess the rate at
which HCVcc productively attaches/interacts with target cells (i.e.
infection initiation) in vitro and identify the factors that inﬂuence the
kinetics observed. Here we show that the rate of HCVcc attachment/
infection initiation in vitro is relatively slow and, more importantly,
that the kinetics are largely determined by the density of the viral
particle relative to the extracellular environment. Our study high-
lights the importance of understanding how the static nature of
traditional cell culturemay artiﬁcially impact the rate of HCV infection
initiation in vitro and the need to carefully consider experimental
HCVcc infection conditions to accurately interpret and study viral
entry in this now widely used experimental model system.
Results
HCVcc infection initiation kinetics
To gain insight into the early steps of HCV infection, we assessed
HCVcc foci formation after increasing viral inoculation periods on
Huh7 cells as a measure of the rate at which HCV virions attach to
target cells to initiate a productive infection in vitro. We utilized a 48 h
end-point focus forming assay in which naïve Huh7 cells were
inoculated with ~100 FFU of JFH-1 HCVccwt. To determine the number
of productive “infection initiation” events (i.e. productive interactions
with target cells) that had occurred at speciﬁc time points p.i., the
inoculumwas removed from triplicate wells at frequent time intervals
p.i. (e.g. 30 min or hourly), cells were washed with 1× PBS, cDMEM
containing 0.25% methyl cellulose [an inert substance routinely used
in virus titration assays tominimize secondary spread (Cooper, 1967)]
was added and the infection was allowed to proceed for a total of 48 h
prior, such that discrete HCV-speciﬁc foci (consisting of 4–8 HCV
NS5A-positive Huh7 cells grouped as one focal point) could be
detected by standard immunohistochemical staining as described in
Materials and methods.
The data in Fig. 1 (representative of four separate experiments,
Supplemental Fig. 1) illustrates the mean number of foci achieved at
each time point over the course of a 48 h infection period. Contrary to
HCVpp (Supplemental Fig. 2) in which 100% productive infection is
initiated within 6 h and other viral systems (Bagai and Lamb, 1995;
Hung et al., 1999; Kartenbeck et al., 1989) in which 100% infection
occurs within several hours, our results indicated that HCVcc infection
initiation events occurred over an extended window of time. We
observed a rapid increase in foci formation (1st slope=7.5±standarderror (SE) 0.8 foci/h) during the ﬁrst ~6 h of inoculation (Fig. 1);
however, from ~6 to 22 h post-inoculation HCVcc foci formation
continued to increase, albeit at a slower rate (2nd slope=3.2±
0.2 foci/h). This was followed by a plateau (i.e., foci slope=0.19±
0.23 which is not signiﬁcantly (p=0.42) different than zero; Fig. 1).
The same pattern was observed in the three additional experiments
shown in Supplemental Fig. 1.
High-density HCVcc particles disappear from viral inoculum sooner than
low-density HCVcc particles
In addition to the prolonged rate of infection initiation observed in
Fig. 1, HCVcc foci formation appeared biphasic followed by a plateau
(termed here multi-phasic), suggesting that the viral inoculum may
contain a heterogeneous population of virions that attach/interact
with target cells at different rates. Since HCVser (Andre et al., 2002)
and HCVcc (Supplemental Fig. 3A) both exhibit broad-density proﬁles
(1.01–1.16 g/ml), we hypothesized that the multi-phasic kinetics of
infection initiation observed might be due to the varying densities of
the HCVcc particles present in the inoculum. To test this hypothesis,
we repeated the 48 h foci assay described above, but in parallel
infected larger cultures so that sufﬁcient material would be available
to assess the density proﬁle of the HCVcc particles remaining in the
inoculum over time. For these scaled up infections, 6-well plate
cultures were infected with HCVccwt at an MOI of 1.0 FFU/cell and at
indicated times p.i. the viral inoculum was removed and stored at
−80 °C. To determine the buoyant density proﬁle of the infectious
particles remaining in the inoculum after 3, 7, 12 and 24 h incubation
with the cells, samples were thawed, overlaid onto discontinuous
iodixanol gradients (10–50% in TNE) and individual fractions were
titrated for virus infectivity and HCV RNA per fraction determined by
RT-qPCR as described in Materials and methods. The data demon-
strate that over time HCVcc infectious virions disappeared from the
viral inoculum (Fig. 2A) in a density-dependent manner, with virions
of higher densities (N 1.07 g/ml) no longer detectable by 7 h p.i.,
which is the approximately the time in which foci formation rate
slowed (Fig. 1). In contrast, particle stability, as measured by RNAse
resistant HCV RNA levels present in the fraction (Kim et al., 2006), did
not signiﬁcantly ﬂuctuate from 0 to 12 h p.i. (pN0.05) (Fig. 2B). Only
at 24 h p.i. was there a signiﬁcant (pb0.01) decrease (~1 log) in HCV
RNA levels as compared to input levels (Fig. 2B). Taken together, these
data suggested that that the disappearance of HCVcc virions of high
Fig. 2.HCV particles of higher density disappear/loose infectivity faster than particles of
lower density after inoculation into cell cultures. Cultures of Huh7 cells seeded in 6-well
plates, were infected in parallel with HCVccwt at a MOI of 1.0 FFU/cell in a total
inoculum volume of 1 ml and at indicated time points p.i., medium was removed from
inoculated cultures and frozen at−80 °C. Inoculum collected at 0, 3, 7, 12 and 24 h p.i.
were thawed and fractionated by discontinuous iodixanol gradient centrifugation (10–
50% in TNE). Individual fractions were collected, titrated for virus infectivity and HCV
RNA levels determined by RT-qPCR analysis. (A) Titers are presented as a percentage of
the total sum of infectious virus present in all fractions. (B) HCV RNA levels are
presented as viral genome copies/ml present in all fractions at each time point.
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was not due to loss of particle integrity, but rather a consequence of
virions attaching to/interacting with target cells. Thus, the rate at
which HCVcc virions initiate productive infection in vitro is dependent
on the density of the virion, with more dense particles becoming
associated with the Huh7 cells during the ﬁrst, more rapid foci for-
mation phase.
The rate of HCVcc infection initiation in vitro is density-dependent
Tomore directly test this hypothesis, we separated HCVcc particles
of different densities and measured the relative rate at which these
different density particles initiated foci formation in vitro. For this
analysis, 1.2 ml of a concentrated 1×106 FFU/ml HCVccwt stock was
separated by ultracentrifugation and fractions were collected and
analyzed for HCV RNA and infectivity (data not shown). A 48 h focus
forming assay, as detailed in Fig. 1, was then performed with the
1.01 g/ml and 1.09 g/ml density fractions to determine the rate atwhich HCVcc virions within two different densities fractions initiated
productive foci formation (Fig. 3A). Consistent with particles of higher
density attaching to and/or interacting with target cells sooner than
particles of lower density, the rate of foci formation calculated in
cultures infected with 100 FFU of HCVcc from the 1.09 g/ml density
fraction was signiﬁcantly higher (p=0.0002) when compared to the
number of foci achieved in cultures infected with HCVcc from the
1.01 g/ml density fraction (Fig. 3A). This difference in infection
initiation kinetics was particularly evident during the ﬁrst 12 h p.i.
(Fig. 3B). Interestingly, the rate of foci formation was not multi-phasic
as observed for HCVccwt (Fig. 1), but rather single-phasic from 0.5 to
24 h p.i. for HCVcc from both the 1.09 g/ml and 1.01 g/ml density
fractions (slopes of 1.30±0.05 and 1.04±0.04 foci/h, respectively).
These single-phase increase slopes (rather than the biphasic increase;
e.g., Fig. 1) are likely a direct result of using a more homogenous viral
inoculum of similar density virions as opposed to using an unpuriﬁed
inoculum containing heterogeneous broad-density virions (e.g.
HCVccwt).
In addition to analyzing fractions of HCVccwt of different densities,
we also assessed the infection initiation rate of the mutant virus JFH-
1G451R (HCVccG451R) (Zhong et al., 2006), which has been shown to
have enhanced infectivity in vitro as well as a distinct density proﬁle
as compared to HCVccwt. Speciﬁcally, Zhong et al. (2006) showed that
a glycine-to-arginine mutation at position 451 (G451R) in the viral E2
glycoprotein resulted in production of HCVcc having a narrower
density range with a higher average mean density. After introducing
this mutation into the JFH-1 coding sequence and verifying that we
observed a higher mean density proﬁle and more robust HCVccG451R
infectivity kinetics, similar to that described by Zhong et al. (2006)
(Supplemental Fig. 3B and C), we tested whether HCVccG451R ex-
hibited faster infection initiation kinetics than HCVccwt. We found
that when comparing HCVccwt with HCVccG451R ﬁrst phase increase
(0–6 h p.i.) was 4.85±0.36, versus 6.25±0.76 foci/h, respectively,
and 2.98±0.18, versus 2.64±0.21 foci/h, respectively, during the
second/slower phase (6–20 h p.i.). Foci number accumulation
slowed signiﬁcantly for both viruses 20 h p.i. onwards with slopes
of 0.24± 0.08 foci/h (HCVccwt) versus 0.22± 0.08 foci/
h (HCVccG451R). By comparing the slopes we found that the kinetics
of HCVcc foci formation between the two viruses were not
signiﬁcantly (pN0.1) different. However importantly, HCVccG451R
foci levels were always signiﬁcantly (pb0.05) higher than HCVccwt
foci levels. Thus, consistent with particles of higher density initiating
productive infection sooner than particles of lower density, the results
demonstrate that higher a percentage of HCVccG451R attaching to and/
or interacting with target cells sooner than HCVccwt (Fig. 4), a
characteristics that likely at least in part explains the enhanced
infectivity exhibited by this mutant virus.
The rate of HCVcc infection initiation can be altered by changing the
density of the culture medium
Because the density of complete DMEM supplemented with 10%
FBS is ~1.05 g/ml and the majority of infectious HCVccwt particles
have a density between 1.01 and 1.09 g/ml, we reasoned that the
ability of some infectious HCVcc virions to reach their target cells in
vitro is hindered because ~60% of infectious particles are less dense
than the density of the standard culture medium and would thus tend
to “ﬂoat” rather than sink to the cell monolayer like most other
viruses, whose densities are greater than 1.11 g/ml (Burtonboy et al.,
1993; Hirano et al., 1978; Huang et al., 2004; Kokorev et al., 1976;
Macnaughton and Davies, 1980; Niiyama et al., 1975; Smith et al.,
1970; Weiss et al., 1996). To test the hypothesis that the relative
density of HCVcc particles versus the culture medium inﬂuences the
kinetics of infection in vitro, we ﬁrst analyzed HCVcc RNA kinetics
following infection in cDMEM supplemented with 1, 10 and 20% FBS,
which correspond to media densities of 1.02, 1.05 and 1.07 g/ml,
Fig. 3.HCV particles of higher density exhibit faster infection initiation kinetics. Huh7 cells were plated in 96-well plates, infected with ~100 FFU of 1.01 g/ml (open circles) or 1.09 g/
ml (grey diamonds) density fractions of HCVccwt in 1% cDMEM. At indicated time points p.i., inoculum was removed from triplicate wells, cells were washed twice with 1× PBS and
overlaid with 10% cDMEM containing 0.25% methylcellulose. Forty-eight hours p.i., HCV foci were visualized by HRP-based immunocytochemistry staining using an anti-NS5A
antibody, quantiﬁed and are expressed as mean number (no.) of foci detected/well ± stdev for triplicate samples. Time course of infection initiation is shown over (A) 36 h
(additionally, the average number of foci obtained after maximal foci formation was observed (23–36 h p.i.) is shown) and (B) 12 h.
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of density). As shown in Fig. 5, the kinetics of HCVcc RNA ampliﬁcation
differed based on the density of the extracellular medium. Twenty-
four hours p.i., themean intracellular HCV RNA level was 8-fold higher
in cultures in which HCVcc infectionwas performed in the presence of
1% FBS as compared to 10% FBS (p=0.05). Likewise, a mean 3-fold
reduction in intracellular HCV RNA was detected in cultures in which
HCVcc infection was performed in the presence of 20% FBS as
compared to 10% FBS (p=0.05). The differences observed at 48 and
72 h p.i. were also signiﬁcantly different (p=0.05) (Fig. 5).
To speciﬁcally assess infection initiation kinetics, we performed a
foci formation time course assay with HCVccwt (Fig. 6A and B) and
HCVccG451R (Fig. 6C and D) in the presence of increasing concentra-
tions of FBS. We observed that the rate of HCVccwt foci initiation was
multi-phasic (biphasic followed by plateau) inmedium containing 1%,
10% or 20% FBS (Fig. 6A). In medium containing 1%, 10% or 20% FBS the
ﬁrst phase (~0–6 h p.i.) foci formation rate decreased from 4.69±
0.92, 3.06±0.45 and 1.01±0.27 foci/h, respectively, and the second
phase (~6–20 h p.i.) foci formation rate decreased from 2.96±0.41,
1.81±0.15 and 0.47±0.11 foci/h, respectively. By comparing theFig. 4.Mutations that alter HCV particle density affect viral infection initiation kinetics. Huh7
or HCVccG451R (open squares) and at indicated time points p.i., inoculum was removed from
containing 0.25% methylcellulose. Forty-eight hours p.i., HCV foci were visualized by HRP-ba
mean number (no.) of foci detected/well ± stdev for triplicate samples. Linear trend linesslopes we found that the kinetics of HCVccwt foci formation among the
different medias were signiﬁcantly different (pb0.01) except for the
ﬁrst phase increase in media containing 1% (1.02 g/ml) and 10%
(1.05 g/ml) FBS (p=0.12). Taken together, these data demonstrate
that the rate of HCVccwt foci initiationwas enhancedwhen the density
of the medium was lowered to 1.02 g/ml and signiﬁcantly inhibited
when increased to 1.07 g/ml (Fig. 6A and B).
The rate of HCVccG451R foci initiation was also multi-phasic in
mediumcontaining 1%, 10% or 20% FBS (Fig. 6C). Inmediumcontaining
1%, 10% or 20% FBS, the ﬁrst phase (~0–6 h p.i.) foci formation rate
decreased 5.77±0.50, 3.20±0.32 and 2.03±0.25 foci/h, respectively,
and 1.61±0.24, 1.08±0.11 and 0.53±0.13 foci/h, respectively,
during the second phase (~6–20 h p.i,). By comparing the foci
formation slopes among the medium concentrations we found that
all were signiﬁcantly different from each other (p≤0.05); however,
this effect was not as visually prominent as compared to HCVccwt
(Fig. 6B vs. D). Particularly during the ﬁrst 12 h p.i. with HCVccG451R,
when the majority of highly infectious 1.07–1.09 g/ml HCVccG451R
particles would be expected to rapidly “sink” to the surface of the cell
monolayer in DMEM supplemented with either 1% FBS (1.02 g/ml),cells were plated in 96-well plates, infected with ~100 FFU of HCVccwt (grey diamonds)
triplicate wells, cells were washed twice with 1× PBS and overlaid with 10% cDMEM
sed immunocytochemistry staining using an anti-NS5A antibody and are expressed as
are depicted to help illustrate the underlying difference between the two viruses.
Fig. 5. Reducing the density of the extracellular environment affects HCV infection
initiation kinetics. Huh7 cells were plated in 96-well plates, infected with HCVccwt at a
MOI of 0.1 FFU/cell in cDMEM containing 1% (diamonds), 10% (squares) or 20% (circles)
FBS. At indicated time points p.i., inoculum was removed from triplicate wells,
intracellular RNA was collected and HCV RNA and cellular GAPDH RNA were quantiﬁed
by RT-qPCR. HCV RNA is expressed as HCV copies/μg total cellular RNA. Results are
graphed as mean ± stdev (n=3). * p value=0.05.
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initiation kinetics with HCVccG451R inoculated in the different serum
concentrations was observed (Fig. 6D). However, by 12 h p.i., the
kinetics of HCVccG451R foci formation more closely paralleled that of
HCVccwt (Fig. 6A vs. C), which is consistent with the fact that the
HCVccG451R stock did contain some lighter particles (Supplemental
Fig. 3B) that would be expected to be sensitive to the density of the
extracellular environment.
Recognizing that FBS is not an inert substance andwhen present at
high concentrations (e.g. 20%) FBS could have a negative impact on
the cells and/or virus, we attempted to alter the density of the culture
mediumwith inert substances such as iodixanol, sucrose and glycerol,
but, the concentrations of these reagents required to achieve ﬁnal
densities of 1.05 and 1.07 g/ml were cytotoxic and therefore we were
unable to alter the density of the medium by these means (data not
shown). As an alternative approach, to determine if the effects we had
observed were due to some non-speciﬁc effect of the FBS, we tested
whether concentrations of FBS from 1 to 20% had similar effects on
other viral infections. Speciﬁcally, we assessed pseudoparticle entry in
the presence of increasing concentrations of FBS, and observed that
the rates of HCVpp (JFH-1 and H77) and VSVGpp entry were
unaffected at any of the FBS concentrations tested (Fig. 7). This
would imply that FBS present in the culture medium, at concentration
from 1 to 20%, has no indirect negative effects on the cells or E1/E2
bearing viral particles. Lastly, we tested whether these same
concentrations of FBS from 1 to 20% had any effect on HCV replication
post-attachment/entry. For these experiments, Huh7 cells were
inoculated with HCVccwt at an MOI of 1.5 FFU/cell for 12 h and
subsequently cultured in the presence of increasing concentrations of
FBS. Cellular HCV RNA levels were assessed by RT-qPCR to assess
ampliﬁcation of HCV RNA from 12 to 24 h. As expected, HCV RNA
replication levels were not affected at any of the FBS concentrations
tested (Supplemental Fig. 4). Thus, the effects observed on HCVcc
entry (Fig. 6) are instead, as hypothesized, likely density-related.
Discussion
HCV entry represents a key step in the viral lifecycle and a
promising target for the development of novel therapeutics to preventHCV infection and spread. Although prior work using HCVpp has
identiﬁed essential HCV receptors and demonstrated that post-
binding internalization of E1/E2 containing particles is relatively
slow (i.e. 300 min to achieve 100% entry) (Dreux et al., 2006;
Meertens et al., 2006), we are still far from fully understanding all the
steps of this complex and dynamic process particularly as they occur
during authentic HCV infection. Aiming to gain a better appreciation
of infectious HCVcc entry in vitro, we assessed the rate of HCVcc
attachment/interaction with target cells (i.e. “infection initiation”)
and observed that not only was HCVcc infection initiation slower than
reported for other viruses, but a novel multi-phasic, density-
dependent phenotype was observed, as detailed below.
Kinetics of HCVcc infection initiation
Although exceptions to the rule do exist (Culp and Christensen,
2004), viral entry is generally a rapid and highly efﬁcient event. For
example, SV40 infection of CV-1 cells has been shown to occur with
20–30 min (Kartenbeck et al., 1989), while dengue virus infection has
been shown to occur within 2 h in vitro (Hung et al., 1999). Thus, it
was surprising to ﬁnd that under the experimental conditions
described herein, HCVcc required up to 24 h for the maximum
number of infection initiation event to occur (Fig. 1), suggesting that
productive binding of HCVcc particles to the host cells is not
synchronous in vitro, but rather individual binding events occur
over a signiﬁcant period of time after inoculation of the virus into the
culture.
Since the rate at which viral particles come into contact with their
target cells in vitro can be affected by speciﬁc cell culture conditions
(e.g. inoculation volume and virus-to-cell ratio) as well as extraneous
cell culture manipulations (e.g. culture rocking/shaking and temper-
ature changes), extreme care was taken to ensure that standardized
infection conditions were rigorously followed and that the infected
cultures were handled minimally and in precisely the same manner.
Additionally, when relevant, HCVpp and VSVGpp kinetics were
analyzed as controls for manipulation-speciﬁc effects. For example,
because the kinetic experiments described required a signiﬁcant
amount of culture handling as detailed in Materials and methods,
cDMEM was supplemented with HEPES buffer to ensure proper
buffering, plates were handled for no more than 2 min outside of the
incubator and cultures were always kept at 37 °C by pre-warming all
cell culture reagents used for washes and overlays. Despite taking
excess precautions, however, we of course cannot deﬁnitively rule out
the possibility that mere shifts of O2/CO2 might have potentially
affected cellular conditions and inadvertently skewed our entry
kinetics towards a slower rate than what would be observed in the
absence of such extraneous manipulations. Importantly, however,
identical manipulations during HCVpp and VSVGpp infection did not
result in analogous prolonged infection kinetics (Supplemental Figs. 2
and 5) indicating that this phenotype was HCVcc speciﬁc.
To ensure that our foci counts were reﬂective of only initial
infection events and did not include secondary satellite foci, an
overlay was added to all cultures post-infection, even though studies
from our laboratory demonstrate that following low multiplicity of
infection de novo infectious HCVcc production does not occur until
~48 h p.i. (data not shown). In selecting an overlay, we chose
methylcellulose as this inert substance has been routinely used in
numerous virus titration assays. Although a standard virological
overlay (Cooper, 1967), we nonetheless tested whether the addition
of methylcellulose post-infection could affect viral entry kinetics and
found no signiﬁcant difference in foci numbers at any time point
regardless of methylcellulose addition (data not shown). Likewise,
using the unrelated VSVGpp virus, we show in Supplemental Fig. 5
that the addition of methycellulose to infected cultures post-infection
had no affect (p valueN0.05) on VSVGpp kinetics. Thus, the observed
prolonged HCVcc infection initiation kinetics observed was not
Fig. 6. Reducing the density of the extracellular environment affects the rate of HCV infection initiation. Huh7 cells were plated in wells of a 96-well plate, infected with~100 FFU of
(A and B) HCVccwt or (C and D) HCVccG451R in cDMEM containing 1% (black diamonds), 10% (open squares) or 20% (grey circles) FBS. At indicated time points p.i., inoculum was
removed from triplicate wells, cells were washed twice with 1× PBS and overlaid with 10% cDMEM containing 0.25% methylcellulose. Forty-eight hours p.i., HCV foci were visualized
by HRP-based immunocytochemistry using an anti-NS5A antibody, quantiﬁed and expressed as a mean number (no.) of foci detected/well ± stdev for triplicate samples. Time
course of infection initiation is shown over (A and C) 24 h and (B and D) 12 h.
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methylcellulose in the culture media.
Together with the fact that four independent experiments per-
formedbymultiple individuals yielded identical prolongedmulti-phasic
HCVcc infection initiation kinetics (Fig. 1 and Supplemental Fig. 1) and
that introduced variables (e.g. particle and/or media density) had
reproducible effects on infection initiation kinetics (Figs. 3–6), our
results as awhole suggest that the cell culturemanipulationsperformed,
assay conditions utilized and experimental parameters followed were
not responsible for the unique HCVcc infection kinetics observed but
rather, HCVcc entry is indeed a slow and prolonged process.
HCVcc particle density is a determinant of viral infection initiation
kinetics in vitro
Of particular interest was the fact that in addition to HCVcc
attachment to target cells occurring over a large window of time, the
rate of this infection initiation was not linear as is routinely observed
for other viral systems, including HCVpp (Supplemental Fig. 2).
Rather, the rate at which HCVcc initiated productive infection of Huh7
cells appeared multi-phasic (Fig. 1 and Supplemental Fig. 1). We
reasoned that since i) the same prolonged, multi-phasic pattern wasnot recapitulated by HCVpp (Supplemental Fig. 2), which is produced
in lipoprotein-deﬁcient 293T embryonic kidney cells (Farquhar and
McKeating, 2008), and ii) viral association with lipoproteins con-
tributes to the broad-density proﬁle of HCV (Andre et al., 2002;
Gastaminza et al., 2006; Zhong et al., 2005) (Supplemental Fig. 3A),
which is unlike the majority of other viruses that exhibit uniform
density (Burtonboy et al., 1993; Hirano et al., 1978; Huang et al., 2004;
Kokorev et al., 1976; Macnaughton and Davies, 1980; Niiyama et al.,
1975; Smith et al., 1970; Weiss et al., 1996), that the prolonged and
multi-phasic rate of infection initiation observed (Fig. 1) might be
directly due to HCVcc virions of differing density existing in the viral
inoculum.
By analyzing the density of HCVcc virions remaining in the culture
medium following viral inoculation, we initially found that infectious
HCVcc particles of particular buoyant densities disappeared from the
viral inoculum at different rates (Fig. 2). Interestingly, however, if the
HCV particles were disappearing due to productive attachment/
interaction to target cells, we would have initially predicted the loss of
less dense particles ﬁrst since low-density HCV particles have been
shown to have higher speciﬁc infectivity than high-density particles
(Lindenbach et al., 2005; Zhong et al., 2006). Instead, we observed the
loss of denserHCVparticles before that of less dense particles such that
Fig. 7. The density of the extracellular environment does not affect HCVpp or VSVGpp
entry. Huh7 cells were plated in 96-well plates and infected with equal titer amounts of
(A) JFHpp, (B) H77pp or (C) VSVGpp in cDMEM containing 1% (ﬁlled diamonds), 10%
(open squares) or 20% (shaded circles) FBS. At indicated time points p.i., inoculum was
removed from triplicate wells, cells were washed twice with 1× PBS and overlaid with
10% cDMEM. Seventy-two hours p.i., wells were lysed and infection quantiﬁed by
relative light units (RLU) ± stdev (n=3).
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were detectable in the viral inoculum (Fig. 2B). Thus, we concluded
that the high-density particles must have either i) become associated
with the cells prior to low-density particles, ii) were signiﬁcantly less
stable than the low-density particles, or iii) that the disappearance of
high-density particles was a consequence of denser particles picking
up lipoproteins present in the medium during infection and thus
becoming less dense over time.
Although all three conclusions are plausible and may contribute to
the observed phenotype, our data most directly support that high-
density particles productively interact with cells faster than low-
density particles (i.e. conclusion “i”). We tested this hypothesis by
fractionating HCVcc virions by density gradient ultracentrifugation
and directly assessing the rate at which low- versus high-density HCV
particles initiated productive infection in vitro (Fig. 3). Consistent with
idea that denser HCV particles attach and interact with target cells
ﬁrst (asmeasured by HCV foci formation), HCVccwithin the 1.09 g/ml
density fraction initiated productive foci formation more efﬁciently
than the virus within the 1.01 g/ml density fraction (Fig. 3B). Furthersupporting our hypothesis that the multi-phasic nature of HCVccwt
foci formation (Fig. 1) is due to the HCVcc virions of differing density
existing in the viral inoculum, a linear increase in foci formation was
observed for HCVcc in both the 1.01 g/ml and 1.09 g/ml density
factions (Fig. 3A). These more linear kinetics are likely a direct result
of using an inoculum containing more homogenous virions of similar
density as opposed to using an inoculum containing heterogeneous
virions with a broad range of densities (e.g. HCVccwt).
Importantly, analysis of particle stability over time (as determined
by measuring RNase resistant HCV RNA) indicated that high-density
HCV particles were as stable as low-density particles over the course
of infection (Fig. 2B), suggesting that the immediate loss of high-
density particles from the inoculum during infection is not a
consequence of particle stability (i.e. conclusion “ii”), but rather a
result of these particles interacting with cells prior to virions of lower
density. Lastly, since both the 1.01 g/ml and 1.09 g/ml HCVcc virions
were produced and subsequent experimental infections were per-
formed in identical cDMEM supplemented with only 1% FBS it is
unlikely that the HCV particles rapidly became lipidated by FBS
components during the course of this analysis (i.e. conclusion “iii”).
Hence, take together, our data supports conclusion i, in which the
different infection initiation rates observed with the 1.01 and 1.09 g/
ml HCV particles (Fig. 3B) represents a density-associated HCV
particle characteristic independent of particle decay or lipidation.
Notably our second method of testing whether particles of high-
density interact with target cells sooner in vitro, also conﬁrmed this
conclusion as the HCVccG451R adaptivemutant, which has been shown
to exhibit a higher mean density (1.07–1.09 g/ml) than HCVccwt,
exhibited faster infection initiation kinetics than HCVccwt (Figs. 4
and 6). Thus together these data support the conclusion that the
density of the HCV particle predominantly inﬂuences the rate at
which the virus attaches/interacts with target cells in vitro.
Density of the cell culture medium is a major determinant of HCV
infection initiation kinetics in vitro
The observation that HCV particles of higher density exhibit faster
infection initiation kinetics in vitro despite the fact that less dense HCV
particles have a higher intrinsic speciﬁc infectivity (Haid et al., 2009;
Lindenbach et al., 2005; Zhong et al., 2006), suggested to us that the in
vitro cell culture environment might be artiﬁcially inﬂuencing the rate
at which HCVcc interacts with target cells. Speciﬁcally, since we
measured cell culture medium supplemented with 10% FBS to have a
density of 1.05 g/ml and the majority of infectious HCVcc has a
density of≤1.09 g/ml, one would assume that the density of the
medium might impede the some of the more highly infectious HCVcc
virions from reaching the cell monolayer. To test this hypothesis, we
decreased and increased the density of the extracellular environment
by altering the percentage of serum in the medium and assessed
whether HCVcc infection initiation was enhanced or impaired,
respectively (Figs. 5 and 6). As predicted, reducing serum to 1% (i.e.
reducing medium density to 1.02 g/ml) enhanced infection initiation
kinetics, suggesting that when the medium was less dense (1% FBS),
HCVcc virions of a broader range of densities could more readily sink
to the cell monolayer essentially increasing the rate at which virion-
cell interactions occurred. In contrast, when the medium density was
increased to 1.07 g/ml (20% FBS) fewer HCVcc particles (i.e. only
those with a density≥1.07 g/ml) could rapidly sink to interact with
target cells. The observed phenotypes were HCVcc-speciﬁc and not
due to any indirect negative effects of FBS, as neither HCV RNA
replication post-entry nor HCVpp (JFH-1 and H77) or VSVGpp entry
kinetics were affected by the varying concentration of serum present
in the media (Supplemental Figs. 4 and 7, respectively). Taken
together, these observations would suggest that the kinetics of HCVcc
infection initiation in vitro is directly affected by the density of the
particle relative to the density of the extracellular milieu.
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Because HCV particles of high-density are able to more efﬁciently
sink to the cell monolayer and interact with target cells faster than
low-density particles in vitro, it is likely that the higher average
buoyant density of the HCVccG451R mutant drove the selection of this
adaptive mutation during long term propagation in vitro and in turn
explains its enhanced in vitro infectivity. Notably however, the loss of
viral-associated lipoproteins would not necessarily be advantageous
in vivo as such associations are believed to provide particle stability
(Burlone and Budkowska, 2009), confer a mechanism of escape from
the humoral immune response (Andre et al., 2002) and enhance in
vivo infectivity (Andreo et al., 2007; Burlone and Budkowska, 2009;
Lindenbach et al., 2006). The latter is supported by the fact that virus
recovered from mice and chimpanzees infected with HCVcc have a
higher speciﬁc activity and are of lower buoyant density than the virus
produced in cell culture (Lindenbach et al., 2006). Therefore, while in
vitro adaptive mutations conferring HCV particles with higher buoy-
ant density, such as the G451Rmutation, provide useful research tools
(Grove et al., 2008), their in vivo ﬁtness may be compromised as is
often the case with tissue-culture adapted viruses.
Conclusions
We show that in vitro HCVcc attachment/interaction with target
cells is a slow process, affected by the density of both the viral particle
and the extracellular culture medium. During infection in vitro, HCVcc
particles must sink through the medium to efﬁciently reach their
target cells, therefore viral particles with buoyant densities higher
than the culture medium are able to reach the cells sooner than
particles with a buoyant density lower than the culture medium.
Although this phenotype is an in vitro phenomenon, it nonetheless
reveals the importance of a previously unrecognized variable (i.e.
density of the culture medium) inherent in the HCV infectious cell
culture system. While it is generally accepted that in vivo infection
conditions cannot be perfectly modeled in vitro, this study highlights
that extreme care must be taken to at least ensure that the in vitro
conditions themselves do not limit infection or result in misinterpre-
tation of viral life cycle parameters (e.g. infection initiation kinetics).
Whether this in vitro restriction has previously impeded our ability to
efﬁciently culture other HCV genotypes in cell culture (Pietschmann
et al., 2009; Yi et al., 2006) remains to be determined; however, the
observations presented herein certainly suggest that cell culture
practices, such as infections in low-serum medium, might enhance
our ability to propagate different HCV clones in vitro.
Materials and methods
Cells
Huh7 cells [also known as Huh7/scr (Gastaminza et al., 2006; Zhong
et al., 2006) and Huh7-1 (Sainz et al., 2009) cells)] were obtained from
Dr. Francis Chisari (The Scripps Research Institute, La Jolla, CA) (Zhong
et al., 2005), andwere cultured in complete Dulbecco's modiﬁed Eagle's
medium (cDMEM) (Hyclone, Logan, UT) supplemented with 10% fetal
bovine serum (FBS) (Hyclone), 100 units/ml penicillin, 100 mg/ml
streptomycin, and 2 mM L-glutamine (Gibco Invitrogen, Carlsbad, CA).
Cell culture propagated HCV (HCVcc)
The genotype 2a JFH-1 plasmid (pJFH-1) has been previously
described (Wakita et al., 2005). The JFH-1G451R expression plasmid
(pJFH-1G451R), which contains a glycine-to-arginine mutation at amino
acid residue 451 in the E2 glycoprotein (Zhong et al., 2006), was
generated by site-directed mutagenesis of pJFH-1 using a complemen-
tary pair of oligomers of sequence 5’-CAA CTC TTC AAG GTG TCC TGAGAGGTT GGC C-3’ and the QuickChange II XL site-directedmutagenesis
kit (Stratagene, La Jolla, CA), as per the manufacturer's instructions.
Viral stocks of wild-type (wt) JFH-1 (HCVccwt) or JFH-1G451R
(HCVccG451R) were generated as previously described (Sainz et al.,
2009). Supernatants from infected cells were collected and centri-
fuged at 4000 rpm for 5 min to remove cellular debris, infectivity
titers were determined as described below and when indicated,
concentrated 10-fold by centrifugal ﬁlteration (Amicon Ultra; Milli-
pore, Billerica, MA).
Forty-eight hour foci formation assay
In order to achieve a cell conﬂuence of 80% at the time of
inoculation, ~5000 Huh7 cells were seeded in each well of a 96-well
plate (Corning, Lowell, MA). Exactly 24 h post-seeding, wells were
inoculated with ~100 focus forming units (FFU) of HCVccwt or
HCVccG451R in a total volume of 100 μl cDMEM containing 1, 10 or 20%
FBS. At indicated times post-infection (p.i.), the inoculum was
removed from triplicate wells, cells were washed twice with pre-
warmed (i.e. 37 °C) 1× phosphate buffered saline (PBS), and
monolayers overlaid with 200 μl of pre-warmed cDMEM containing
a ﬁnal concentration of 0.25% methylcellulose (vol/vol) (Fluka
BioChemika, Switzerland). Forty-eight hours p.i., cells were ﬁxed in
4% paraformaldehyde (Sigma, St. Louis, MO), and HCV-speciﬁc foci
detected by immunohistochemical staining using a mouse monoclo-
nal anti-NS5A antibody E910 (Lindenbach et al., 2005) as described in
(Sainz et al., 2009).
Density gradient ultracentrifugation
Iodixanol (OptiPrep Solution, Axis-Shield, Norton, MA) density
gradients were prepared in Beckman UltraClear 14 by 89 mm
ultracentrifugation tubes as a step gradient of 10–50% iodixanol in
TNE (150 mM NaCl, 10 mM Tris-HCl and 2 mM EDTA, pH 8). One to
1.5 ml of viral sample was layered on top of the gradient and
separated by ultracentrifugation in a SW41Ti (Beckman Coulter, Inc.
Fullerton, CA) rotor at 125,000×g for 16 h at 4 °C. One milliliter
gradient factions were collected from the top of the gradient and
titrated for virus infectivity or analyzed for HCV RNA as described
below. Fraction densities were determined by measuring the mass of
50 μl aliquots of each sample.
Infectivity titration assay
Culture supernatants or iodixanol gradient fractions (diluted 1:2
with cDMEM) were serially diluted 10-fold and used to infect
duplicate 96-well Huh7 cultures. At 24 h p.i., cultures were overlaid
with cDMEM to a ﬁnal concentration of 0.25% methylcellulose (Fluka
BioChemika) to limit long distance extracellular spread and resulting
secondary satellite foci formation. Seventy-two hours p.i., cells were
ﬁxed in 4% paraformaldehyde (Sigma), and immunohistochemically
stained for HCV NS5A using a mouse monoclonal anti-NS5A antibody
E910 (Lindenbach et al., 2005). Viral titers are expressed as FFU/ml,
determined by the average NS5A-positive foci number detected at the
highest HCV-positive dilution, foci being deﬁned as discrete areas of
HCV-positive cells.
HCV infection kinetics
Huh7 cells were seeded at 4×103 cells in each well of a 96-well
plate (Corning). Twenty-four hours post-seeding, cells were infected
with HCVccwt at a multiplicity of infection (MOI) of 0.01 FFU/cell in a
total volume of 100 μl cDMEM containing 1, 10 or 20% FBS. At
indicated times p.i., total cellular RNA was harvested from triplicate
wells for reverse transcription followed by real-time quantitative PCR
(RT-qPCR) analysis.
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Total cellular RNA was isolated using a 1× Nucleic Acid Puriﬁcation
Lysis Solution (Applied Biosystems, Foster City, CA) and puriﬁed using
an ABI PRISM™ 6100 Nucleic Acid PrepStation (Applied Biosystems), as
per the manufacturer's instructions. Total RNA from gradient fractions
was isolatedby theguanidine thiocyanate (GTC)methodusing1.6XGTC
containing 2 μg of murine liver RNA and following standard protocols
(Chomczynski and Sacchi, 1987). RNA (1 μg) was used for cDNA
synthesis using TaqMan reverse transcription reagents (Applied
Biosystems), followed by SYBR green RT-qPCR using an Applied
Biosystems 7300 real-time thermocycler as previously described (Choi
et al., 2009). HCV transcript levels were determined relative to a
standard curve of serially diluted JFH-1 plasmid and normalized to
GAPDH. The PCR primers used to detect GAPDH and HCV were: human
GAPDH (NMX002046) 5'-GAAGGTGAAGGTCGGAGTC-3' (sense) and 5'-
GAAGATGGTGATGGGATTTC-3' (antisense), murine GAPDH (M32599)
5'-TCTGGAAAGCTGTGGCGTG-3' (sense) and5'-CCAGTGAGCTTCCCGTT-
CAG-3' (antisense) and JFH-1 HCV (AB047639) 5'-TCTGCGGAACCGGT-
GAGTA-3' (sense) and 5'-TCAGGCAGTACCACAAGGC-3' (antisense).
Pseudotyped retroviral particle production and infections
Pseudotyped viruses were produced as previously described
(Sainz et al., 2009). Brieﬂy, DNA encoding HCV E1/E2 (JFH-1 or
H77) or VSV G glycoproteins were co-transfected along with the Env-
deﬁcient HIV vector carrying a luciferase reporter gene (pNL4-3-Luc-
R--E-) into 293T producer cells. The supernatants containing the
pseudotyped viruses were collected 48 h post-transfection and
ﬁltered through a 0.45 μm-pore-size ﬁlter (BD Biosciences, San Jose,
CA), aliquoted, frozen and subsequently titered using the QuickTiter
Lentivirus Titer Kit (Cell Biolabs, Inc., San Diego, CA) according to the
manufacturer's instructions.
For experimental HCVpp infections, Huh7 cells were seeded at
4×103 cells in 96-well plates (Corning). Twenty-four hours post-
seeding, cellswere infectedwithequal titersof pseudotypedvirus andat
indicated time points the inoculums were removed, cells were washed
twicewith 1×PBS, and overlaidwith 100 μl cDMEM. Seventy-twohours
p.i., all cultureswere lysed in 20 μl of lysis reagent and luciferase activity
wasmeasured with a luciferase assay kit (Promega, Madison,WI) and a
FLUOstarOptimamicroplate reader (BMGLabtechnologies Inc,Durham,
NC) according to manufacturer's protocol.
Statistical analysis
To compare foci number obtained among the different viruses or
medium conditions at each time point, we used the Kruskal–Wallis
Test and subgroups analysis was performed using the Mann–Whitney
test. To determine whether foci increase slopes differ among viruses
or medium conditions, we used a linear regression model (S-PLUS,
V.8, Seattle, WA). The slope of this linear regression line represents
the best estimate of foci increase rate. In addition, we included a
standard error (SE) interval to indicate the reliability of each estimate.
The analysis includes p value (two tailed), testing the null hypothesis
that the slope is not different than zero; if the p value is higher than
5%, we conclude that the slope is not different than zero. In all cases, a
two-sided p value of ≤0.05 was considered signiﬁcant.
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